Inside the Practice: Inside STELARA's Approval

Jennifer Davidson, DO, discusses the recent FDA approval of ustekinumab (STELARA) to treat pediatric patients with active psoriatic arthritis with a focus on advancing care in psoriatic disease and new strategies to increase diversity in rheumatology.